Leap Therapeutics focuses on developing DKN-01, a promising monoclonal antibody for solid tumors, with encouraging early ...
As we enter 2025, global markets have shown a mixed performance with the S&P 500 and Nasdaq Composite closing out another strong year despite some end-of-year volatility. This backdrop of fluctuating ...
In a time when personalized solutions are reshaping industries, Harpreet Singh’s work explores the profound influence of Big Data on revolutionizing personalized medicine. As healthcare increasingly ...
As global markets navigate a mixed landscape with the S&P 500 Index closing out a strong year despite recent volatility, attention is turning to small-cap stocks, which have shown resilience amid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback